The document provides brokerage reports from various firms on different companies. Goldman Sachs maintains an 'Outperform' rating for HDB Financial with a target price of Rs 2,735 and says its ALM profile is well matched. Macquarie maintains a 'Buy' for Motherson Sumi but cuts its target price and cites slowing car demand. HSBC upgrades Bajaj Finance to 'Buy' with a higher target, citing improved asset quality and loan growth. Morgan Stanley maintains an 'Add' for Kotak Securities with a higher target, noting management's confidence in growth and margins. Lupin announces an out-licensing deal for novel oncology drugs.